Cramer's 'Stop Trading': AT&T, Verizon
Jim Cramer says that Verizon and AT&T's stock may be boring, but he's still a fan.
03:42PM 12/08/09
Cell Therapeutics on Dilution Watch: BioBuzz
CEO spotted in New York with bankers in tow, looking at his wallet.
02:16PM 12/08/09
Ariad, Cephalon Make ASH Splash: BioBuzz
News and highlights from the American Society of Hematology annual meeting.
10:45AM 12/08/09
Expecting a Rebound (Deep in the Money Calls $)
This inexpensive biopharmaceutical stock has been putting in a base since the spring and now seems to be on the mend.
10:01AM 12/04/09
Cephalon Sues Teva Over Sleep Drug Nuvigil
Cephalon has sued Teva for violating 2 patents on sleep disorder drug Nuvigil
05:26PM 12/02/09
Biotech Calendar: Key Dates for December
A calendar of important, potentially stock-moving biotech events for December.
09:56AM 11/30/09
'Fast Money' Recap: Mutual Fund Monday
Pete Najarian said today's rally follows a predictable pattern of previous Mondays that has seen a large flow of money coming in at the beginning of the week.
08:06PM 11/23/09
Blood Cancer Meeting Abstracts Released: BioBuzz
No data in Celgene abstract, disappointing investors.
12:16PM 11/10/09
Bristol Licenses Arthritis Drug: BioBuzz
Worldwide deal involves privately held Alder BioTherapeutics
09:20AM 11/10/09
Celgene in ASH Abstract Spotlight: BioBuzz
A blood cancer meeting also is important for Onyx, Cephalon and Ariad.
06:31AM 11/10/09
Bulls Buy Cephalon, WebMD:Options Recap
Bullish traders bet on Cephalon, Smithfield Farms and WebMD.
04:17PM 11/09/09
Alkermes Takes 2Q Loss, Cuts Full-year Estimates
Alkermes reports loss, and expects lower Risperdal Consta and Vivitrol revenue in fiscal 2010
06:48PM 11/05/09
Biotech Calendar: Key Dates for November
Your quick-and-dirty guide to key dates and events for biotech investors during November.
07:12AM 11/02/09
Covidien Gets Approval For Generic Pain Drug Actiq
Covidien says FDA approved its version of Actiq, a powerful drug used against cancer pain
04:45PM 10/30/09



Connect with TheStreet